working 24/7 for truth and honesty
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
what??? it doesnt say that at all
nope it doesnt say that at all LOL LOL
i dont see her name here, maybe i missed it LOL LOL
https://expertscape.com/ex/glioblastoma
nice picture so what
yeah so what?
Lol lots of oncologists have been supported for years . Nope sorry no one thinks she is the best
Best in the world ??? Lol I havent seen one professional org claim that !!!
nonsense, there are 100s of equally if not more qualified oncologists. and many would have the backbone to stand up to management with their wack ideas about conducting a study
just like the 70ish docs that support dccrap
LOL i have been got a paper published in a second rate journal, that missed some important stuff like data manipulation. LOL Lead author does interview and claims fda manga=dated crossover, but oops SAP is published and says nope, not fda mandated, Stock nosedives LOL
yep paying attention
it is a civil case LOL
well that is one of the few times I have heard NWBO execs described as capable LOL
It is a good thing you arent as even if they lose the case, the penalties are usually not that severe, but in this case the odd of losing the case for defendants are very very low
really On JAMA?????? LOL
tey might consider starting a real trial that would allow foe RA approval, not the crap they currently have
note the "company believes" which is a legal way of saying it is NOT a fact
it does not assert that at all.
oh, wow, so it is a turbo charged cease and desist. Not just a regular cease and desist.LOL LOL
unless one is involved with one of the defendants that is not relevant
probably will. this move of desperation on the part of the company is a sure sign that this POS is facing a sure demise
what are those teeth????
right on Matt!!! et al LOL LOL
say, what did that JAMAonc "paper" do for the stock price??????
so what, he makes money. what kind of crime is that?
LOL so the "proof" is that he uses a competitive product. Hysterically funny
LOL that is the everyday norm with eltp
massive eh, i am guessing 10K lol lol
great article thanks . It tales a special skill set to understand this tech
I have a new appreciation for NASRAT LOL LOL
if i need something mechanical fixed I will call smith
left out. paid consultant to nwbo, thanks for the reminder
who??????????
yeah, but what can the company say??? maybe: whoops we got this crap study published and no one believed it LOL
Prove it
Soc??? There are serious doubts it even works how would it be Soc????
Lol sure they are
Larry is a mechanical engineer, hmmmmm sort of like a poli sci major LOL LOL
uh oh, LOL LOL
nonsense, there is not a mention of crossover in the paper, LOL oh, and dont forget this:
The use of external control arms in oncology is an evolving
area of methodological advancement and regulatory interest. Thus far, external control data have been limited to
establishing natural history or providing supportive data
analyses affording clinical context for an observed treatment effect. These data have not provided pivotal support
as substantial evidence of treatment effectiveness in
oncology, and therefore have not yet been included in the
prescription drug labeling. In the future, it is possible that
formal analyses for comparative treatment effect between
an investigational therapy and an external control arm
would provide the primary evidence of efficacy to support a
regulatory approval in oncology, particularly for a disease
type with a highly predictable natural history and the precisely measurable treatment effect.
As described in previous sections, t